Benefits and Drawbacks of Emergency Use Authorizations for COVID Vaccines
The EUA pathway may impede vital scientific progress needed to establish the long term safety and efficacy of investigational COVID-19 vaccines.

The EUA pathway may impede vital scientific progress needed to establish the long term safety and efficacy of investigational COVID-19 vaccines.

We can simultaneously get COVID vaccines to those most at risk while minimizing harm to our ability to fully evaluate their safety and efficacy.

The failure to control the COVID-19 pandemic in the United States rests, in part, on the individualist nature of our public health responses.

The CDC already has all the power it needs to limit the movement of people in order to slow the spread of COVID-19.

Paying for vaccination is dubious public health policy likely to backfire in terms of (re)building public trust in vaccines.

Can private businesses mandate that employees and customers receive COVID-19 vaccines authorized for emergency use?

In the past weeks, three companies in advanced stages of COVID-19 vaccine trials reported good news. What does this mean?

Slashing Medicare reimbursement for safety-net hospitals may have devastating effects on the individuals who rely on these hospitals.

Experts are calling into question the recent decision of the U.S. Food and Drug Administration to approve remdesivir for the treatment of COVID-19.
